Cancer, Advanced Not Yet Recruiting Phase 1 Trials for Pembrolizumab (DB09037)

Also known as: Advanced Cancer / Cancer / Neoplasm malignant / Malignant neoplasm NOS / Cancer NOS / Malignant tumor / Malignant tumour / Cancer (NOS) / Malignant neoplasm without specification of site

IndicationStatusPhase
DBCOND0041606 (Cancer, Advanced)Not Yet Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03546426Pembrolizumab Plus Autologous Dendritic Cell Vaccine in Patients With PD-L1 Negative Advanced Mesothelioma Who Have Failed Prior TherapiesTreatment